Stemnovate: Funding, Investors & Team (Sep 2026)
Stemnovate is a unique, innovative drug development platforms enable the right patients to be targeted with the right treatments, at the right time.
Stemnovate has raised $1.2M across 1 funding round on record, the most recent a Grant of $1.2M announced in Aug 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Stemnovate Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Stemnovate Funding Rounds
Stemnovate Founders and Leadership Team
No contact details are on record for this team yet.
Stemnovate Funding Compared to Other Biotechnology Startups
Stemnovate's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Stemnovate in Biotechnology and Babraham
Companies Similar to Stemnovate
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Stemnovate Funding FAQs
What does Stemnovate do?
Stemnovate is a unique, innovative drug development platforms enable the right patients to be targeted with the right treatments, at the right time.
How much funding has Stemnovate raised?
Stemnovate has raised $1.2M across 1 round on record. The most recent is a Grant of $1.2M announced in Aug 2022.
When did Stemnovate last raise funding?
Stemnovate's most recent funding round on record is a Grant of $1.2M, announced in Aug 2022.
Who founded Stemnovate?
FundedIQ lists Adrian Fisher (Founder) at Stemnovate.
Where is Stemnovate headquartered?
Stemnovate is based in Babraham, Cambridgeshire, United Kingdom.
How many employees does Stemnovate have?
Stemnovate is in the 11-50 employee band.
How does Stemnovate's funding compare to other Biotechnology startups?
Stemnovate's latest round of $1.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Stemnovate Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Stemnovate is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.